Pangea Bio
Piers Morgan has extensive experience in the financial sector, holding various CFO and executive positions in companies within the pharmaceutical and biotech industries. With a background in law and management studies from the University of Cambridge, Piers has led successful IPOs, equity financings, and partnerships throughout their career. Their current role as Chief Financial Officer at Pangea Botanica involves accelerating drug discovery inspired by nature while preserving ethnobotanical knowledge.
Pangea Bio
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.